Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Gsk Plc ADR
(NY:
GSK
)
44.59
UNCHANGED
Streaming Delayed Price
Updated: 11:48 AM EDT, May 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gsk Plc ADR
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
28
29
Next >
Benzinga Before The Bell: Amazon Wages Price War On Tesco, Biden's Campaign Promise To Free Cannabis Prisoners, H&M Exits Russia And Other Top Financial Stories Monday, July 18
July 18, 2022
Reuters GSK Completes Spin-Off Of Its Consumer Healthcare Business
Via
Benzinga
GSK Completes Spin Off Of Its Consumer Healthcare Business
July 18, 2022
Via
Benzinga
The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures
July 14, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Theravance Biopharma, Innoviva Gain On Selling TRELEGY ELLIPTA Royalty Interests
July 13, 2022
Via
Benzinga
GSK Shares Encouraging Data From Chronic Hepatitis B Candidate
June 27, 2022
Via
Benzinga
Best Stocks For 2022 Recession
June 18, 2022
Recession is in the air in 2022, and I have 3 stocks for recession-proofing your portfolio. Let's look at Walmart, Raytheon Tech, and GlaxoSmithKline.
Via
Talk Markets
Antibiotic Makers Adopt Their Own Environmental Safeguard Standards
June 15, 2022
Via
Benzinga
Science Wednesday: Where To See Comet K2 As It Passes The Earth
July 13, 2022
Five years ago, astronomers were electrified to confirm the discovery of Comet C/2017 K2, more commonly known as Comet K2. At the time, it was believed to be one of the largest comets zooming across...
Via
Benzinga
The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner
July 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
7 Retirement Stocks to Buy in July
July 01, 2022
Planning for retirement can feel overwhelming in bear markets, but these seven retirement stocks can provide a boost to savings. Caterpillar (CAT): The
Via
InvestorPlace
Ideaya Nominates Potential First-In-Class Pol Theta Helicase Inhibitor In Collaboration With GSK
June 28, 2022
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
June 27, 2022
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...
Via
Benzinga
GSK Shows Positive Pivotal Phase III Data For Its RSV Vaccine Candidate
June 10, 2022
Via
Benzinga
FDA Approves GSK's Measles Vaccine
June 06, 2022
Via
Benzinga
The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies
June 27, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
With Zero Revenue, Laekna Plays Chicken-And-Egg Game With Investors
June 24, 2022
Key Takeaways: Laekna is seeking a Hong Kong IPO to raise funds to accelerate the commercialize two core products licensed from Novartis The company currently is not generating...
Via
Benzinga
Finally An Omicron-Blocking Shot? Sanofi, GSK Say Yes
June 24, 2022
The companies' shot was more than 93% effective in previously infected people.
Via
Investor's Business Daily
Benzinga Before The Bell: Gun Safety Bill. Bill Gates's North Dakota Outrage, Sanofi-GSK's Covid-19 Vaccine's Omicron Efficacy And Other Top Financial Stories Friday, June 24
June 24, 2022
Reuters
Via
Benzinga
Sanofi-GSK's Beta-Containing COVID-19 Vaccine Shows Efficacy Against Omicron
June 24, 2022
Via
Benzinga
This Pharmaceutical Company Is Moving Beyond CBD
June 23, 2022
The applications for cannabidiol (CBD) and cannabinoid-based therapeutics are many. Many novel treatments have been, and are continuing to be, discovered using these compounds. The industry is huge...
Via
Benzinga
Analyzing GSK's Short Interest
June 15, 2022
GSK's (NYSE:GSK) short percent of float has fallen 17.24% since its last report. The company recently reported that it has 6.02 million shares sold short, which is 0.24% of all...
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, June 13
June 13, 2022
CNBC JPMorgan Remains Bullish On Alibaba And Other Chinese Stocks - Here’s Why
Via
Benzinga
Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern
June 13, 2022
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Friday, June 10
June 10, 2022
Reuters Rebranded McDonald’s Restaurants To Reopen In Russia
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, June 6
June 06, 2022
Reuters
Via
Benzinga
The Week Ahead In Biotech (June 5-11): Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More
June 05, 2022
Biotech stocks reversed course along with the broader market and closed the week ending June 3 lower. The sector's lean run thus got extended.
Via
Benzinga
Week In Review: Vivo Raises $600 Million In First Tranche Of China PE Fund
June 04, 2022
Vivo Capital held its first closing of a yuan-denominated private equity fund at $600 million, with a target of bringing the fund to $1.5 billion. Meanwhile, ProfoundBio closed a $70 million Series A+...
Via
Talk Markets
6 Biotech Stocks to Buy Now Ahead of These June Catalysts
June 03, 2022
These biotech stocks face some key make-or-break events in June that could have big implication for their futures.
Via
InvestorPlace
3 Undervalued Dividend Growth Stocks
June 01, 2022
Investors who focus on a strategy of dividend growth stocks have performed better than some broader stock market indices.
Via
InvestorPlace
GSK Confirms Consumer Healthcare Unit Spin-off: What Investors Should Know
June 01, 2022
Close on the heels of an M&A deal, GlaxoSmithKline plc (NYSE: GSK) confirmed the spin-off of the consumer healthcare business it jointly owns with U.S. pharma giant Pfizer, Inc.
Via
Benzinga
< Previous
1
2
...
12
13
14
15
16
17
18
19
20
...
28
29
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.